Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Fusion Pharmaceuticals Inc.
Tanabe Pharma America, Inc.
Xencor, Inc.
Roswell Park Cancer Institute
SWOG Cancer Research Network
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Case Comprehensive Cancer Center